Health Cor Management, L.P. Veracyte, Inc. Transaction History

Health Cor Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $2.63 Million - $5.09 Million	-119,710 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $2.53 Million - $3.77 Million	70,070 Added 141.16%	119,710 $4.93 Million
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $1.77 Million - $2.63 Million	49,640 New	49,640 $2.31 Million

257

81.7M

43K

82K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.55B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.